14
Participants
Start Date
February 28, 2007
Primary Completion Date
May 31, 2013
Study Completion Date
May 31, 2013
Carvedilol Controlled Release (CR)
"lisinopril starting dose in all patients 10 mg QD for 1 week then increase to 20 mg QD throughout the study.~Initial dose: Carvedilol CR (20 mg QD, dose level 1) Titration: If tolerated, increase the dosage to 20 mg QD, 40 mg QD, and 80mg QD orally over successive intervals of at least 2 weeks to achieve target blood pressure sSBP \<130 and sDBP \< 80"
lisinopril
lisinopril starting dose in all patients 10 mg QD for 1 week then increase to 20 mg QD throughout the study
Diabetes - Endocrinology Center of Western New York, Buffalo
Collaborators (1)
GlaxoSmithKline
INDUSTRY
University at Buffalo
OTHER